c‐Src, Insulin‐Like Growth Factor I Receptor, G‐Protein‐Coupled Receptor Kinases and Focal Adhesion Kinase are Enriched Into Prostate Cancer Cell Exosomes

It is well known that Src tyrosine kinase, insulin‐like growth factor 1 receptor (IGF‐IR), and focal adhesion kinase (FAK) play important roles in prostate cancer (PrCa) development and progression. Src, which signals through FAK in response to integrin activation, has been implicated in many aspects of tumor biology, such as cell proliferation, metastasis, and angiogenesis. Furthermore, Src signaling is known to crosstalk with IGF‐IR, which also promotes angiogenesis. In this study, we demonstrate that c‐Src, IGF‐IR, and FAK are packaged into exosomes (Exo), c‐Src in particular being highly enriched in Exo from the androgen receptor (AR)‐positive cell line C4‐2B and AR‐negative cell lines PC3 and DU145. Furthermore, we show that the active phosphorylated form of Src (SrcpY416) is co‐expressed in Exo with phosphorylated FAK (FAKpY861), a known target site of Src, which enhances proliferation and migration. We further demonstrate for the first time exosomal enrichment of G‐protein‐coupled receptor kinase (GRK) 5 and GRK6, both of which regulate Src and IGF‐IR signaling and have been implicated in cancer. Finally, SrcpY416 and c‐Src are both expressed in Exo isolated from the plasma of prostate tumor‐bearing TRAMP mice, and those same mice have higher levels of exosomal c‐Src than their wild‐type counterparts. In summary, we provide new evidence that active signaling molecules relevant to PrCa are enriched in Exo, and this suggests that the Src signaling network may provide useful biomarkers detectable by liquid biopsy, and may contribute to PrCa progression via Exo. J. Cell. Biochem. 118: 66–73, 2017. © 2016 Wiley Periodicals, Inc.

[1]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.

[2]  R. Matusik,et al.  Prostate cancer in a transgenic mouse. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[3]  S. L. Warren,et al.  pp60(c-src) modulates microvascular endothelial phenotype and in vitro angiogenesis. , 2001, Experimental and molecular pathology.

[4]  D. Hanahan,et al.  Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis. , 2002, Cancer cell.

[5]  F. Peruzzi,et al.  The IGF‐1 receptor in cancer biology , 2003, International journal of cancer.

[6]  D. Troyer,et al.  Phosphorylation of Akt (Ser473) is an Excellent Predictor of Poor Clinical Outcome in Prostate Cancer , 2004, Cancer Research.

[7]  Dan Theodorescu,et al.  Angiogenesis and prostate cancer tumor growth , 2004, Journal of cellular biochemistry.

[8]  Aled Clayton,et al.  Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids , 2006, Current protocols in cell biology.

[9]  J. Riedemann,et al.  IGF1R signalling and its inhibition. , 2006, Endocrine-related cancer.

[10]  G. Bartsch,et al.  Androgen axis in prostate cancer , 2006, Journal of cellular biochemistry.

[11]  J. Violin,et al.  β-Arrestin–mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection , 2007 .

[12]  Lucia R Languino,et al.  The integrin—growth factor receptor duet , 2007, Journal of cellular physiology.

[13]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[14]  Thomas J Mitchell,et al.  Src Family Kinase Activity Is Up-Regulated in Hormone-Refractory Prostate Cancer , 2009, Clinical Cancer Research.

[15]  Samuel A Wickline,et al.  Paracrine induction of endothelium by tumor exosomes , 2009, Laboratory Investigation.

[16]  Graça Raposo,et al.  Exosomes--vesicular carriers for intercellular communication. , 2009, Current opinion in cell biology.

[17]  S. Lim,et al.  Hypoxic Tumor Cell Modulates Its Microenvironment to Enhance Angiogenic and Metastatic Potential by Secretion of Proteins and Exosomes* , 2010, Molecular & Cellular Proteomics.

[18]  Hamid Cheshmi Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers , 2011 .

[19]  E. Kohn,et al.  Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a src-dependent fashion , 2011, Angiogenesis.

[20]  D. Cheresh,et al.  Tumor angiogenesis: molecular pathways and therapeutic targets , 2011, Nature Medicine.

[21]  H. Klocker,et al.  Targeting the insulin-like growth factor network in cancer therapy , 2011, Cancer biology & therapy.

[22]  V. Rangnekar,et al.  Mechanisms of apoptosis by the tumor suppressor Par‐4 , 2012, Journal of cellular physiology.

[23]  C. Logothetis,et al.  Combined Inhibition of IGF-1R/IR and Src Family Kinases Enhances Antitumor Effects in Prostate Cancer by Decreasing Activated Survival Pathways , 2012, PloS one.

[24]  Gema Moreno-Bueno,et al.  Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET , 2012, Nature Medicine.

[25]  P. Chakraborty,et al.  G-protein coupled receptor kinase 5 regulates prostate tumor growth. , 2011, The Journal of urology.

[26]  T. Issad,et al.  Selective recruitment of G protein-coupled receptor kinases (GRKs) controls signaling of the insulin-like growth factor 1 receptor , 2012, Proceedings of the National Academy of Sciences.

[27]  Naved Alam,et al.  Insulin‐like growth factor 1 stimulation of androgen receptor activity requires β1A integrins , 2012, Journal of cellular physiology.

[28]  M. Benson,et al.  Characterization of Human Thymic Exosomes , 2013, PloS one.

[29]  E. Yu,et al.  Insulin-like growth factor receptor-1 (IGF-IR) as a target for prostate cancer therapy , 2014, Cancer and Metastasis Reviews.

[30]  P. Corn,et al.  Src signaling pathways in prostate cancer , 2014, Cancer and Metastasis Reviews.

[31]  B. Bao,et al.  Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review , 2013, Cancer and Metastasis Reviews.

[32]  L. Languino,et al.  IGF-IR Promotes Prostate Cancer Growth by Stabilizing α5β1 Integrin Protein Levels , 2013, PloS one.

[33]  J. Siddiqui,et al.  Trop-2 promotes prostate cancer metastasis by modulating β(1) integrin functions. , 2013, Cancer research.

[34]  D. Quail,et al.  Microenvironmental regulation of tumor progression and metastasis , 2014 .

[35]  C. Nelson,et al.  Exosomes in Prostate Cancer: Putting Together the Pieces of a Puzzle , 2013, Cancers.

[36]  I. Leav,et al.  β1 integrins mediate resistance to ionizing radiation in vivo by inhibiting c‐Jun amino terminal kinase 1 , 2013, Journal of cellular physiology.

[37]  A. Alva,et al.  The changing natural history of metastatic prostate cancer. , 2013, Cancer journal.

[38]  Hong-Jian Zhu,et al.  Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components , 2013, Proteomics.

[39]  George A Calin,et al.  Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. , 2014, Cancer cell.

[40]  J. Gutkind,et al.  Novel insights into G protein and G protein-coupled receptor signaling in cancer. , 2014, Current opinion in cell biology.

[41]  F. Luo,et al.  Recent advances in bone-targeted therapies of metastatic prostate cancer. , 2014, Cancer treatment reviews.

[42]  Amos Tanay,et al.  Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancer. , 2014, Cell reports.

[43]  C. Théry,et al.  Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. , 2014, Annual review of cell and developmental biology.

[44]  Michael A. Hollingsworth,et al.  Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver , 2015, Nature Cell Biology.

[45]  L. Larue,et al.  Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines , 2015, Pigment cell & melanoma research.

[46]  Bernd Thiede,et al.  Identification of prostate cancer biomarkers in urinary exosomes , 2015, Oncotarget.

[47]  F. Real,et al.  Intratumour heterogeneity in urologic cancers: from molecular evidence to clinical implications. , 2015, European urology.

[48]  W. Westbroek,et al.  Exosomes Released from Breast Cancer Carcinomas Stimulate Cell Movement , 2015, PloS one.

[49]  R. Roskoski,et al.  Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors. , 2015, Pharmacological research.

[50]  Diane D. Liu,et al.  Targeting the insulin-like growth factor receptor and Src signaling network for the treatment of non-small cell lung cancer , 2015, Molecular Cancer.

[51]  R. Iozzo,et al.  The αvβ6 Integrin Is Transferred Intercellularly via Exosomes* , 2015, The Journal of Biological Chemistry.

[52]  Christian Pilarsky,et al.  Glypican-1 identifies cancer exosomes and detects early pancreatic cancer , 2015, Nature.

[53]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[54]  T. Ochiya,et al.  Extracellular Vesicles and Their Role in Urologic Malignancies. , 2016, European urology.